Andrew Goldsweig to Cardiovascular Agents
This is a "connection" page, showing publications Andrew Goldsweig has written about Cardiovascular Agents.
Connection Strength
1.675
-
Ahmad S, Ahsan MJ, Newlun M, Sand M, Rmilah AA, Yousaf A, Shabbir MA, Malik SA, Goldsweig AM. Outcomes of aortic stenosis in patients with cardiac amyloidosis: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 Apr; 73:98-106.
Score: 0.848
-
Goldsweig AM, Tak HJ, Chen LW, Aronow HD, Shah B, Kolte D, Desai NR, Szerlip M, Velagapudi P, Abbott JD. Relative Costs of Surgical and Transcatheter Aortic Valve Replacement and Medical Therapy. Circ Cardiovasc Interv. 2020 05; 13(5):e008681.
Score: 0.611
-
Murali Krishna M, Joseph M, Ezenna C, Pereira V, Jenil Franco A, Ismayl M, Rymer J, Goldsweig AM. Efficacy of paclitaxel-coated versus uncoated balloon angioplasty for revascularization of coronary in-stent restenosis: a meta-analysis and metaregression. Coron Artery Dis. 2025 Nov 01; 36(7):569-579.
Score: 0.216